PHAROMED
The computed 12-month bankruptcy probability of PHAROMED is 0.4% (very low). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 14 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro | 30-04-2025 | 2025-00083468 |
| 31-12-2023 | micro | 14-06-2024 | 2024-00131849 |
| 31-12-2022 | micro | 31-08-2023 | 2023-00417903 |
| 31-12-2021 | micro | 29-08-2022 | 2022-20398903 |
| 31-12-2020 | micro | 27-08-2021 | 2021-56500555 |
| 31-12-2019 | micro | 02-10-2020 | 2020-58700069 |
| 31-12-2018 | micro | 31-07-2019 | 2019-42300099 |
| 31-12-2017 | micro | 04-04-2018 | 2018-09000536 |
| 31-12-2016 | micro | 13-07-2017 | 2017-31200132 |
| 31-12-2015 | volledig | 26-08-2016 | 2016-48800367 |
| NACE primary | 82990 |
| Legal form | Private limited company(610) |
| Incorporation | 06-10-2011 |
| Status | Active |
| Postal code | 4671 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62095A0217/00N000 | Wallonia | 1,500 m² | 1 · 164 m² | 7.7 m · 2 fl. |
| 62019A0450/00M000 | Wallonia | 598 m² | 1 · 103 m² | 6.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
24-11-2023 Transaction in capital or shares
Technical details
{
"events": [
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Benoit ROLANS",
"firm_city": null,
"firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
"office_city": "Herstal",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-11-24",
"filing_date": "2023-11-22",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-11-22",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0839.991.789",
"name_full": "PHAROMED",
"legal_form": "Soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition de l\u0027assembl\u00E9e",
"la coordination des statuts"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "BEN BRAHIM Mehdi",
"role": null,
"n_shares": null,
"share_class": "A"
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "BEN BRAHIM BLOOM Ayo",
"role": null,
"n_shares": null,
"share_class": "A"
}
],
"share_classes_after": [
{
"n_shares": 100,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 3,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PHAROMED |